Current Stem Cell Research and Therapy This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Unlocking the Potential of Induced Pluripotent Stem Cells in Revolutionizing Cancer Therapy
This article highlights the potential of iPSC- based NK cells and dendritic cells for immunotherapy and delves into the role of iPSC-based mesenchymal cells in targeted therapy. The potential of iPSC-derived organoids as a vital tool for disease modeling and drug discovery has been showcased, and the importance of iPSC-based cancer vaccines is also emphasized. The ongoing clinical trials of iPSC-based cancer treatment have also been highlighted. Though much work remains to be done to implicate these iPSC-based therapeutic options from research labs to clinics and hospitals, ongoing studies and clinical/translational follow...
Source: Current Stem Cell Research and Therapy - April 17, 2024 Category: Stem Cells Authors: Amrita Mondal Ankita Talukdar Rizwanul Haque Source Type: research
Unlocking the Potential of Induced Pluripotent Stem Cells in Revolutionizing Cancer Therapy
This article highlights the potential of iPSC- based NK cells and dendritic cells for immunotherapy and delves into the role of iPSC-based mesenchymal cells in targeted therapy. The potential of iPSC-derived organoids as a vital tool for disease modeling and drug discovery has been showcased, and the importance of iPSC-based cancer vaccines is also emphasized. The ongoing clinical trials of iPSC-based cancer treatment have also been highlighted. Though much work remains to be done to implicate these iPSC-based therapeutic options from research labs to clinics and hospitals, ongoing studies and clinical/translational follow...
Source: Current Stem Cell Research and Therapy - April 17, 2024 Category: Stem Cells Authors: Amrita Mondal Ankita Talukdar Rizwanul Haque Source Type: research
Unlocking the Potential of Induced Pluripotent Stem Cells in Revolutionizing Cancer Therapy
This article highlights the potential of iPSC- based NK cells and dendritic cells for immunotherapy and delves into the role of iPSC-based mesenchymal cells in targeted therapy. The potential of iPSC-derived organoids as a vital tool for disease modeling and drug discovery has been showcased, and the importance of iPSC-based cancer vaccines is also emphasized. The ongoing clinical trials of iPSC-based cancer treatment have also been highlighted. Though much work remains to be done to implicate these iPSC-based therapeutic options from research labs to clinics and hospitals, ongoing studies and clinical/translational follow...
Source: Current Stem Cell Research and Therapy - April 17, 2024 Category: Stem Cells Authors: Amrita Mondal Ankita Talukdar Rizwanul Haque Source Type: research
Outcomes of Patients with Heavily Pretreated Relapsed/Refractory Multiple Myeloma Receiving Salvage Cytotoxic Therapy with Supportive Stem Cell Boost
CONCLUSION: This data allow clinicians to appropriately implement and inform patients of the therapeutic uses and clinical outcomes of stem cell boost in patients with multiply relapsed/refractory MM.PMID:38584546 | DOI:10.2174/011574888X287532240325041249 (Source: Current Stem Cell Research and Therapy)
Source: Current Stem Cell Research and Therapy - April 8, 2024 Category: Stem Cells Authors: Ayrton Bangolo Samir Oza Ronit Slotky Aimee Chappell David Siegel Harsh Parmar Noa Biran David H Vesole Pooja Phull Source Type: research
Outcomes of Patients with Heavily Pretreated Relapsed/Refractory Multiple Myeloma Receiving Salvage Cytotoxic Therapy with Supportive Stem Cell Boost
CONCLUSION: This data allow clinicians to appropriately implement and inform patients of the therapeutic uses and clinical outcomes of stem cell boost in patients with multiply relapsed/refractory MM.PMID:38584546 | DOI:10.2174/011574888X287532240325041249 (Source: Current Stem Cell Research and Therapy)
Source: Current Stem Cell Research and Therapy - April 8, 2024 Category: Stem Cells Authors: Ayrton Bangolo Samir Oza Ronit Slotky Aimee Chappell David Siegel Harsh Parmar Noa Biran David H Vesole Pooja Phull Source Type: research
Outcomes of Patients with Heavily Pretreated Relapsed/Refractory Multiple Myeloma Receiving Salvage Cytotoxic Therapy with Supportive Stem Cell Boost
CONCLUSION: This data allow clinicians to appropriately implement and inform patients of the therapeutic uses and clinical outcomes of stem cell boost in patients with multiply relapsed/refractory MM.PMID:38584546 | DOI:10.2174/011574888X287532240325041249 (Source: Current Stem Cell Research and Therapy)
Source: Current Stem Cell Research and Therapy - April 8, 2024 Category: Stem Cells Authors: Ayrton Bangolo Samir Oza Ronit Slotky Aimee Chappell David Siegel Harsh Parmar Noa Biran David H Vesole Pooja Phull Source Type: research
Outcomes of Patients with Heavily Pretreated Relapsed/Refractory Multiple Myeloma Receiving Salvage Cytotoxic Therapy with Supportive Stem Cell Boost
CONCLUSION: This data allow clinicians to appropriately implement and inform patients of the therapeutic uses and clinical outcomes of stem cell boost in patients with multiply relapsed/refractory MM.PMID:38584546 | DOI:10.2174/011574888X287532240325041249 (Source: Current Stem Cell Research and Therapy)
Source: Current Stem Cell Research and Therapy - April 8, 2024 Category: Stem Cells Authors: Ayrton Bangolo Samir Oza Ronit Slotky Aimee Chappell David Siegel Harsh Parmar Noa Biran David H Vesole Pooja Phull Source Type: research
Outcomes of Patients with Heavily Pretreated Relapsed/Refractory Multiple Myeloma Receiving Salvage Cytotoxic Therapy with Supportive Stem Cell Boost
CONCLUSION: This data allow clinicians to appropriately implement and inform patients of the therapeutic uses and clinical outcomes of stem cell boost in patients with multiply relapsed/refractory MM.PMID:38584546 | DOI:10.2174/011574888X287532240325041249 (Source: Current Stem Cell Research and Therapy)
Source: Current Stem Cell Research and Therapy - April 8, 2024 Category: Stem Cells Authors: Ayrton Bangolo Samir Oza Ronit Slotky Aimee Chappell David Siegel Harsh Parmar Noa Biran David H Vesole Pooja Phull Source Type: research
Outcomes of Patients with Heavily Pretreated Relapsed/Refractory Multiple Myeloma Receiving Salvage Cytotoxic Therapy with Supportive Stem Cell Boost
CONCLUSION: This data allow clinicians to appropriately implement and inform patients of the therapeutic uses and clinical outcomes of stem cell boost in patients with multiply relapsed/refractory MM.PMID:38584546 | DOI:10.2174/011574888X287532240325041249 (Source: Current Stem Cell Research and Therapy)
Source: Current Stem Cell Research and Therapy - April 8, 2024 Category: Stem Cells Authors: Ayrton Bangolo Samir Oza Ronit Slotky Aimee Chappell David Siegel Harsh Parmar Noa Biran David H Vesole Pooja Phull Source Type: research
The Renoprotective and Anti-Inflammatory Effects of Human Urine-Derived Stem Cells on Acute Kidney Injury Animals
CONCLUSION: In summary, our results highlighted the effectiveness of USCs in protecting from PTC injury and impeding macrophage polarization, as well as the secretion of pro-inflammatory interleukins, suggesting the potential of USCs as a novel cell therapy in AKI.PMID:38571344 | DOI:10.2174/011574888X296559240326063705 (Source: Current Stem Cell Research and Therapy)
Source: Current Stem Cell Research and Therapy - April 4, 2024 Category: Stem Cells Authors: Yuanyuan Kuang Chenyu Fan Xiaojun Long Jiajia Zheng Yunsi Zeng Yuhui Wei Jiasheng Zhang Shuangjin Yu Tong Chen Hehuan Ruan Yi Wang Ning Na Yiming Zhou Jiang Qiu Source Type: research
The Renoprotective and Anti-Inflammatory Effects of Human Urine-Derived Stem Cells on Acute Kidney Injury Animals
CONCLUSION: In summary, our results highlighted the effectiveness of USCs in protecting from PTC injury and impeding macrophage polarization, as well as the secretion of pro-inflammatory interleukins, suggesting the potential of USCs as a novel cell therapy in AKI.PMID:38571344 | DOI:10.2174/011574888X296559240326063705 (Source: Current Stem Cell Research and Therapy)
Source: Current Stem Cell Research and Therapy - April 4, 2024 Category: Stem Cells Authors: Yuanyuan Kuang Chenyu Fan Xiaojun Long Jiajia Zheng Yunsi Zeng Yuhui Wei Jiasheng Zhang Shuangjin Yu Tong Chen Hehuan Ruan Yi Wang Ning Na Yiming Zhou Jiang Qiu Source Type: research
The Renoprotective and Anti-Inflammatory Effects of Human Urine-Derived Stem Cells on Acute Kidney Injury Animals
CONCLUSION: In summary, our results highlighted the effectiveness of USCs in protecting from PTC injury and impeding macrophage polarization, as well as the secretion of pro-inflammatory interleukins, suggesting the potential of USCs as a novel cell therapy in AKI.PMID:38571344 | DOI:10.2174/011574888X296559240326063705 (Source: Current Stem Cell Research and Therapy)
Source: Current Stem Cell Research and Therapy - April 4, 2024 Category: Stem Cells Authors: Yuanyuan Kuang Chenyu Fan Xiaojun Long Jiajia Zheng Yunsi Zeng Yuhui Wei Jiasheng Zhang Shuangjin Yu Tong Chen Hehuan Ruan Yi Wang Ning Na Yiming Zhou Jiang Qiu Source Type: research
The Renoprotective and Anti-Inflammatory Effects of Human Urine-Derived Stem Cells on Acute Kidney Injury Animals
CONCLUSION: In summary, our results highlighted the effectiveness of USCs in protecting from PTC injury and impeding macrophage polarization, as well as the secretion of pro-inflammatory interleukins, suggesting the potential of USCs as a novel cell therapy in AKI.PMID:38571344 | DOI:10.2174/011574888X296559240326063705 (Source: Current Stem Cell Research and Therapy)
Source: Current Stem Cell Research and Therapy - April 4, 2024 Category: Stem Cells Authors: Yuanyuan Kuang Chenyu Fan Xiaojun Long Jiajia Zheng Yunsi Zeng Yuhui Wei Jiasheng Zhang Shuangjin Yu Tong Chen Hehuan Ruan Yi Wang Ning Na Yiming Zhou Jiang Qiu Source Type: research
Construction of a Cancer Stem Cell related Histone Acetylation Regulatory Genes Prognostic Model for Hepatocellular Carcinoma via Bioinformatics Analysis: Implications for Tumor Chemotherapy and Immunity
CONCLUSION: This study constructed a mRNAsi and HAGs-related prognostic model, which has implications for potential immunotherapy and drug treatment of LIHC.PMID:38561604 | DOI:10.2174/011574888X305642240327041753 (Source: Current Stem Cell Research and Therapy)
Source: Current Stem Cell Research and Therapy - April 1, 2024 Category: Stem Cells Authors: Qian Dai Jie Zhu Jing Yang Chun-Yan Zhang Wen-Jing Yang Bai-Shen Pan Xin-Rong Yang Wei Guo Bei-Li Wang Source Type: research
Construction of a Cancer Stem Cell related Histone Acetylation Regulatory Genes Prognostic Model for Hepatocellular Carcinoma via Bioinformatics Analysis: Implications for Tumor Chemotherapy and Immunity
CONCLUSION: This study constructed a mRNAsi and HAGs-related prognostic model, which has implications for potential immunotherapy and drug treatment of LIHC.PMID:38561604 | DOI:10.2174/011574888X305642240327041753 (Source: Current Stem Cell Research and Therapy)
Source: Current Stem Cell Research and Therapy - April 1, 2024 Category: Stem Cells Authors: Qian Dai Jie Zhu Jing Yang Chun-Yan Zhang Wen-Jing Yang Bai-Shen Pan Xin-Rong Yang Wei Guo Bei-Li Wang Source Type: research